The current analyst and expert consensus on Loxo Oncology is Strong Buy with 0 strong sell and 4 strong buy opinions. The current projected target price consensus is 50.33 with 3 analysts opinions. The most common way Loxo Oncology Inc analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Loxo Oncology executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Loxo Oncology. We encourage you to use your own analysis of Loxo Oncology Inc to validate this buy or sell advice. Loxo Oncology buy or sell recommendation module provides average expert sentiment on the projected Loxo Oncology Inc target price to derive its highest and lowest estimates based on projected price volatility of 1.527. Please see also Macroaxis Advice on Loxo Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.